More about midazolam: not a pretty picture
Our disturbing theory about current clinical practice in end-of-life care Since we published our first article about our families' experiences with the powerful sedative drug midazolam, we have received a lot of correspondence and comments from around the world. As expected, we received one or two defensive comments from medical and nursing professionals. Also as expected, we received a great many very upsetting accounts of similar experiences from people whose aged and sick relatives had received midazolam shortly before they died. Mostly, these people have simply wanted to share their experiences. In some cases they were…
